Skip to content

Precigen PGEN Price / sales

Price / sales at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
2.6×-0.1×
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
5.5×+0.6×
Gilead Sciences logo
Gilead SciencesGILD
5.8×+1.0×
Viridian Therapeutics, Inc. logo
Viridian Therapeutics, Inc.VRDN
28.2×-3,609×
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
30×-15.3×
Arrowhead Research logo
Arrowhead ResearchARWR
14.1×+10.9×

Other financials

Income statement

See full
Revenue$23.3M+1,634%
Operating income-$6.0M+73.5%
Net income-$7.9M+85.4%
EPS (diluted)-$0.02+88.9%

Balance sheet

See full
Cash & equivalents$7.5M+23.5%
Total debt$98.3M+1,714%
Total equity$20.2M+244%
Total assets$138.6M+7.6%

Cash flow

See full
Operating cash flow-$43.8M-168%
CapEx$258.0K-58.5%
Free cash flow-$44.1M-160%

Valuation

See full
Market cap$1.91B+213%
Enterprise value$2B+234%

Profitability

See full
Gross margin83.6%
Operating margin-2,890.9%
Net margin-3,656%
FCF margin-1,756.5%

Returns & leverage

See full
Return on equity-843.6%-1,103pp
Debt / equity4.9×
Current ratio4.8×+1.3×

Where this comes from

Calculated from Precigen’s reported figures.

Based on the most recent quarter.

The official record: Precigen’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Precigen's price / sales.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Precigen's price / sales?
Precigen (PGEN) reported price / sales of 102.3× in Q1 2025.
What is the long-term trend for Precigen's price / sales?
Over 3 years (2020 to 2024), Precigen's price / sales has grown at a 63.5% compound annual growth rate (CAGR), from 19.1× to 83.6×.
What does price / sales mean?
Market capitalization at the quarter end divided by trailing-twelve-month revenue. The price the market pays for each dollar of sales.